VITALISPHARMA.COM: Keyword Density Checker

Total words: 680 | 2-word phrases: 178 | 3-word phrases: 187 | 4-word phrases: 189

PAGE INFO

Title	Try to keep the title under 60 characters (14 characters) Home \| Vitalis
Description	Try to keep the meta description between 50 - 160 characters (106 characters) Vitalis, LLC, is a specialty pharmaceutical company developing proprietary, IP-protected forms of Aspirin.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (104 characters) Aiming to Improve Patients' Lives in Multiple Sclerosis, Post-op Pain (Non-opioid), and Dyslipidemia

#	Keyword	Frequency	Density
1	patients	2	1.07%
2	treatment for ms with	2	1.07%
3	aspirin for postoperative pain	2	1.07%
4	submit nda in 20202021	2	1.07%
5	to submit nda	2	1.07%
6	aiming to submit	2	1.07%
7	aiming to	2	1.07%
8		2	1.07%
9		2	1.07%
10	these patients	2	1.07%
11	for these patients	2	1.07%
12	other clinical benefits	2	1.07%
13	and other clinical	2	1.07%
14	effects and other	2	1.07%
15	for ms with fewer	2	1.07%
16	ms with fewer side	2	1.07%
17	multiple sclerosis postop	2	1.07%
18	potential as a	2	1.07%
19	hold potential as	2	1.07%
20	sclerosis postop pain	2	1.07%
21	vts72 aims to	2	1.07%
22	aims to be	2	1.07%
23	may hold potential	2	1.07%
24	that may hold	2	1.07%
25	therapy that may	2	1.07%
26	to be the	2	1.07%
27	be the next	2	1.07%
28	existing medications	1	0.53%
29	of patient treatment	1	0.53%
30	patient treatment with	1	0.53%

#	Keyword	Frequency	Density
1	aiming to submit	2	1.06%
2	therapy that may hold	2	1.06%
3	for ms with fewer side	2	1.06%
4	treatment for ms with fewer	2	1.06%
5	and other clinical benefits	2	1.06%
6	to submit nda in 20202021	2	1.06%
7	hold potential as a	2	1.06%
8	may hold potential as	2	1.06%
9	that may hold potential	2	1.06%
10	multiple sclerosis postop pain	2	1.06%
11	aiming to submit nda	2	1.06%
12	for these patients	2	1.06%
13	these patients	2	1.06%
14	patients	2	1.06%
15	to be the next	2	1.06%
16	aims to be the	2	1.06%
17	vts72 aims to be	2	1.06%
18		2	1.06%
19	effects and other clinical	2	1.06%
20	product development our	1	0.53%
21	to product development	1	0.53%
22	top of page vts72	1	0.53%
23	research is focused on	1	0.53%
24	is focused on changing	1	0.53%
25	focused on changing the	1	0.53%
26	research to product development	1	0.53%
27	changing the paradigm of	1	0.53%
28	the paradigm of patient	1	0.53%
29	paradigm of patient treatment	1	0.53%
30	of patient treatment with	1	0.53%
31	efforts to discover innovative	1	0.53%
32	to discover innovative uses	1	0.53%
33	on changing the paradigm	1	0.53%
34	we do from early	1	0.53%
35	early research to product	1	0.53%
36	lives of patients this	1	0.53%
37	learn more vitalis is	1	0.53%
38	more vitalis is committed	1	0.53%
39	vitalis is committed to	1	0.53%
40	of page vts72 aims	1	0.53%

#	URL	Whois	Check
1	https://twitter.com/Vitalis_Pharma	Whois	twitter.com
2	https://www.linkedin.com/company/vitalis-llc	Whois	linkedin.com